The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
New aspects of natural products in drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Fungal secondary metabolism — from biochemistry to genomics
Keller, N. P., Turner, G., & Bennett, J. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1286 · Cited by 1,731
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Big Effects from Small Changes: Possible Ways to Explore Nature's Chemical Diversity
Bode, H. B., Bethe, B., Höfs, R., & Zeeck, A. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020703)3:7<619::aid-cbic619>3.0.co;2-9 · Cited by 1,237
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Duvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025999 · Cited by 1,141
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
Regulation of secondary metabolism in streptomycetes
Bibb, M. J. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.02.016 · Cited by 821
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Developing a new resource for drug discovery: marine actinomycete bacteria
Fenical, W., & Jensen, P. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio841 · Cited by 786
Marine-derived fungi: a chemically and biologically diverse group of microorganisms
Bugni, T. S., & Ireland, C. M. (2004) · Natural Product Reports · doi:10.1039/b301926h · Cited by 760
The Renaissance of Natural Products as Drug Candidates
Paterson, I., & Anderson, E. A. (2005) · Science · doi:10.1126/science.1116364 · Cited by 559
Davis, K. E. R., Joseph, S. J., & Janssen, P. H. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.2.826-834.2005 · Cited by 552
Discovery of novel metabolites from marine actinomycetes
Lam, K. S. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.03.004 · Cited by 539
Self-citationNatural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Discovery of a new peptide natural product by Streptomyces coelicolor genome mining
Lautru, S., Deeth, R. J., Bailey, L. M., & Challis, G. L. (2005) · Nature Chemical Biology · doi:10.1038/nchembio731 · Cited by 362
Natural products — The future scaffolds for novel antibiotics?
Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337
Natural products and combinatorial chemistry: back to the future
Ortholand, J.-Y., & Ganesan, A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.011 · Cited by 336
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
Duran, I., Kortmansky, J., Singh, D., Hirte, H., Kocha, W., Goss, G., Le, L., Oza, A., Nicklee, T., Ho, J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603419 · Cited by 317
A genomics-guided approach for discovering and expressing cryptic metabolic pathways
Zazopoulos, E., Huang, K., Staffa, A., Liu, W., Bachmann, B. O., Nonaka, K., Ahlert, J., Thorson, J. S., Shen, B., & Farnet, C. M. (2003) · Nature Biotechnology · doi:10.1038/nbt784 · Cited by 316
Culturable marine actinomycete diversity from tropical Pacific Ocean sediments
Jensen, P. R., Gontang, E., Mafnas, C., Mincer, T. J., & Fenical, W. (2005) · Environmental Microbiology · doi:10.1111/j.1462-2920.2005.00785.x · Cited by 310
Tigecycline: A Critical Analysis
Stein, G. E., & Craig, W. A. (2006) · Clinical Infectious Diseases · doi:10.1086/505494 · Cited by 298
A Convergent Enantioselective Route to Structurally Diverse 6-Deoxytetracycline Antibiotics
Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R., & Myers, A. G. (2005) · Science · doi:10.1126/science.1109755 · Cited by 298
Kwon, H. C., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0558948 · Cited by 294
Lee, M.-L., & Schneider, G. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc000097l · Cited by 293
Diversity of actinomycetes isolated from Challenger Deep sediment (10,898 m) from the Mariana Trench
Pathom-aree, W., Stach, J. E. M., Ward, A. C., Horikoshi, K., Bull, A. T., & Goodfellow, M. (2006) · Extremophiles · doi:10.1007/s00792-005-0482-z · Cited by 280
Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS
Tatsis, E. C., Boeren, S., Exarchou, V., Troganis, A. N., Vervoort, J., & Gerothanassis, I. P. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2006.11.026 · Cited by 260
Nicholson, B., Lloyd, G. K., Miller, B. R., Palladino, M. A., Kiso, Y., Hayashi, Y., & Neuteboom, S. T. C. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000182745.01612.8a · Cited by 260
Eldridge, G. R., Vervoort, H. C., Lee, C. M., Cremin, P. A., Williams, C. T., Hart, S. M., Goering, M. G., O'Neil-Johnso, M., & Zeng, L. (2002) · Analytical Chemistry · doi:10.1021/ac025534s · Cited by 258
Bhadury, P., Mohammad, B. T., & Wright, P. C. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-005-0070-3 · Cited by 250
Combinatorial biosynthesis of antitumor indolocarbazole compounds
Sánchez, C., Zhu, L., Braña, A. F., Salas, A. P., Rohr, J., Méndez, C., & Salas, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407809102 · Cited by 244
McAlpine, J. B., Bachmann, B. O., Piraee, M., Tremblay, S., Alarco, A.-M., Zazopoulos, E., & Farnet, C. M. (2005) · Journal of Natural Products · doi:10.1021/np0401664 · Cited by 231
Drug discovery from natural products
Gullo, V. P., McAlpine, J., Lam, K. S., Baker, D., & Petersen, F. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0107-2 · Cited by 222
Self-citationChemoenzymatic and Template-Directed Synthesis of Bioactive Macrocyclic Peptides
Grünewald, J., & Marahiel, M. A. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.121-146.2006 · Cited by 217
Natural Products: Drug Discovery and Therapeutic Medicine
Zhang, L., & Demain, A. L. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-976-9 · Cited by 213
Diversity and biogeography of marine actinobacteria
Ward, A. C., & Bora, N. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.04.004 · Cited by 183
LC–NMR coupling technology: recent advancements and applications in natural products analysis
Exarchou, V., Krucker, M., van Beek, T. A., Vervoort, J., Gerothanassis, I. P., & Albert, K. (2005) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1632 · Cited by 178
Microbial genomics for the improvement of natural product discovery
Van Lanen, S. G., & Shen, B. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.04.002 · Cited by 166
Macrocyclic ketone analogues of halichondrin B
Zheng, W., Seletsky, B. M., Palme, M. H., Lydon, P. J., Singer, L. A., Chase, C. E., Lemelin, C. A., Shen, Y., Davis, H., Tremblay, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.069 · Cited by 163
A Phase II Study of Depsipeptide in Refractory Metastatic Renal Cell Cancer
Stadler, W. M., Margolin, K. A., Ferber, S., McCulloch, W. F., & Thompson, J. A. (2006) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2006.n.018 · Cited by 151
Combinatorial biosynthesis—Potential and problems
Floss, H. G. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.12.001 · Cited by 151
Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin
Kaur, G., Belotti, D., Burger, A. M., Fisher-Nielson, K., Borsotti, P., Riccardi, E., Thillainathan, J., Hollingshead, M. G., Sausville, E. A., & Giavazzi, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0795 · Cited by 145
A novel proteasome inhibitor NPI-0052 as an anticancer therapy
Chauhan, D., Hideshima, T., & Anderson, K. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603406 · Cited by 141
Tan, G. Y. A., Ward, A. C., & Goodfellow, M. (2006) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2006.01.007 · Cited by 137
Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes
Busti, E., Monciardini, P., Cavaletti, L., Bamonte, R., Lazzarini, A., Sosio, M., & Donadio, S. (2006) · Microbiology · doi:10.1099/mic.0.28335-0 · Cited by 129
Exarchou, V., Fiamegos, Y. C., van Beek, T. A., Nanos, C. G., & Vervoort, J. J. M. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.11.077 · Cited by 111
Natural products as a hunting ground for combinatorial chemistry
Ganesan, A. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.09.002 · Cited by 94
Selection of Retapamulin, a Novel Pleuromutilin for Topical Use
Rittenhouse, S. F., Biswas, S., Broskey, J. P., McCloskey, L., Moore, T. D., Vasey, S. Y., West, J. M., Zalacaín, M., Zonis, R., & Payne, D. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00178-06 · Cited by 90
Analysis of myxobacterial secondary metabolism goes molecular
Bode, H. B., & Müller, R. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0082-7 · Cited by 87
Balamurugan, R., Dekker, F. J., & Waldmann, H. (2005) · Molecular BioSystems · doi:10.1039/b503623b · Cited by 77
BANSKOTA, A. H., McAlpine, J. B., Sørensen, D., Aouidate, M., Piraee, M., Alarco, A., Ōmura, S., Shiomi, K., Farnet, C. M., & Zazopoulos, E. (2006) · The Journal of Antibiotics · doi:10.1038/ja.2006.24 · Cited by 75
Bambeke, F. V. (2006) · PubMed · Cited by 73
Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent
Fulco, P. P., & Wenzel, R. P. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.6.939 · Cited by 71
Muraymycins, novel peptidoglycan biosynthesis inhibitors: synthesis and SAR of their analogues
Yamashita, A., Norton, E. B., Petersen, P. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00671-1 · Cited by 69
Brandi, L., Fabbretti, A., Teana, A. L., Abbondi, M., Losi, D., Donadio, S., & Gualerzi, C. O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507740102 · Cited by 68
Chartreusin, Elsamicin A and Related Anti-Cancer Antibiotics
Portugal, J. (2003) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011033482215 · Cited by 56
Wender, P. A., Baryza, J. L., Brenner, S. E., Clarke, M. O., Craske, M., Horan, J. C., & Meyer, T. (2004) · Current Drug Discovery Technologies · doi:10.2174/1570163043484888 · Cited by 52
Leeds, J. A., Schmitt, E. K., & Krastel, P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.3.211 · Cited by 44
Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2
Kiefer, W., & Dannhardt, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043363668 · Cited by 43
Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria
He, H. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1884-z · Cited by 30
Kim, E., & Shin, W.-H. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.217 · Cited by 25
Accessorizing natural products: Adding to nature's toolbox
Lamb, S. S., & Wright, G. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408858102 · Cited by 25
Kegler, C., Gerth, K., & Müller, R. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.10.007 · Cited by 19
Cited by
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance
Gouda, S., Das, G., Sen, S. K., Shin, H.-S., & Patra, J. K. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01538 · Cited by 869
Metadata
- Authors
- Lam, K. S.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 15
- Issue
- 6
- Pages
- 279-289
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W1972770043
- Cited by
- 531
- References
- 66
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.